PYC Therapeutics Limited ( (AU:PYC) ) just unveiled an announcement.
PYC Therapeutics Limited has announced the application for the quotation of 32,313,759 ordinary fully paid securities on the Australian Securities Exchange (ASX), with the issue date set for April 24, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility, potentially impacting its market positioning and providing opportunities for stakeholders.
More about PYC Therapeutics Limited
PYC Therapeutics Limited operates in the biotechnology industry, focusing on developing precision medicines. The company is engaged in the research and development of therapies aimed at treating genetic diseases, leveraging its proprietary RNA technology platform.
YTD Price Performance: -21.37%
Average Trading Volume: 548,347
Technical Sentiment Signal: Buy
Current Market Cap: A$567.5M
For detailed information about PYC stock, go to TipRanks’ Stock Analysis page.